Thursday, February 26, 2015
Member Benefits
  • Continuing Education Opportunities
  • Professional Advocacy
  • Networking Opportunities  
  • Learn More...





 

Click below to purchase eBooks. 
Use Code NJ2014 for NJSHP.

ASHP Health-System Pharmacy News

Thu, 26 Feb 2015 00:00:00 -0500

On back-to-back legislative days in late January, Democratic and Republican representatives and senators in Congress introduced the Pharmacy and Medically Underserved Areas Enhancement Act.

Thu, 26 Feb 2015 00:00:00 -0500

Heritage Pharmaceuticals Inc. (PDF) on Tuesday announced it was recalling 10 lots of colistimethate and 3 lots of rifampin vials because an FDA inspection of the manufacturer's site revealed practices that could affect product sterility.

Tue, 24 Feb 2015 00:00:00 -0500

Sagent Pharmaceuticals Inc. on Monday announced it was recalling six lots of atracurium besylate 10-mg/mL injection vials because an FDA inspection of the contract manufacturer's site revealed practices that could affect product sterility.

Tue, 24 Feb 2015 00:00:00 -0500

FDA and Novartis on Monday announced the approval of panobinostat, a histone deacetylase (HDAC) inhibitor, for the third-line treatment of multiple myeloma.

Mon, 23 Feb 2015 00:00:00 -0500

Even though the Centers for Medicare and Medicaid Services (CMS) wants to restrict coverage of Part D prescriptions to those written by healthcare professionals enrolled in Medicare, the agency hasn't figured out what to do about pharmacists with prescribing authority.

Sponsors
Home   |   Membership   |   Chapters   |   Councils   |   Events   |   Resources   |   Employment   |   About Us
Copyright 2012 by NJSHP